Home   »   DST selects Acculi Labs to develop...

DST selects Acculi Labs to develop Lyfas COVID score

Acculi Labs, a Bangalore based startup has been selected by Centre for Augmenting WAR with COVID-19 Health Crisis (CAWACH), an initiative by the Department of Science and Technology (DST) to develop Lyfas COVID score, a COVID risk assessment profile. Lyfas, an android application captures the capillary pulse and blood volume change when individual keeps the index finger on the rear phone camera of a mobile phone for 5 minutes. It also derives 95 biomarkers with proprietary algorithms and signal processing techniques. It also utilizes the power of smartphone processor and smartphone sensors to record a bunch of body signals.

All the above parameters have been planned to be repurposed with the Lyfas COVID score. CAWACH is supporting market-ready innovations to the control COVID-19 and helps the startup ideas to address associated challenges.

DST selects Acculi Labs to develop Lyfas COVID score_4.1